ID   MOLM-20
AC   CVCL_2121
SY   MOLM20
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473490
DR   Cosmic; 1012098
DR   DSMZ; ACC-591
DR   DSMZCellDive; ACC-591
DR   Wikidata; Q54906328
RX   PubMed=16408098;
RX   PubMed=31160637;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~70 hours (DSMZ=ACC-591).
CC   HLA typing: A*26:02:01,26:03:01; B*15:01:01,40:06:01; C*03:03:01,08:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,02:01:02; DRA*01:01:01,01:01:01; DRB1*09:01:02,09:01:02 (DSMZCellDive=ACC-591).
CC   Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 25589; SEPTIN11; Name(s)=KMT2A-SEPTIN11, KMT2A-SEPT11, MLL-SEPT11 (PubMed=31160637; DSMZ=ACC-591).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 14,15
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 10
ST   FGA: 21,22
ST   Penta D: 10,12
ST   Penta E: 8,12
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3179; Chronic neutrophilic leukemia
DI   ORDO; Orphanet_86829; Chronic neutrophilic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V650 ! CNLBC1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 22
//
RX   PubMed=16408098; DOI=10.1038/sj.leu.2404081;
RA   Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.;
RT   "JAK2 V617F tyrosine kinase mutation in cell lines derived from
RT   myeloproliferative disorders.";
RL   Leukemia 20:471-476(2006).
//
RX   PubMed=31160637; DOI=10.1038/s41598-019-44491-x;
RA   Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M.,
RA   MacLeod R.A.F., Nagel S., Steube K., Uphoff C.C., Drexler H.G.;
RT   "The LL-100 panel: 100 cell lines for blood cancer studies.";
RL   Sci. Rep. 9:8218-8218(2019).
//